How Demis Hassabis, the CEO of Google DeepMind, is Advancing AI Through Scientific Discovery
How Demis Hassabis, the CEO of Google DeepMind, is Advancing AI Through Scientific Discovery
摘要: About Us
Trending
Contact Us
Advertise
UAE Edition
Rankings
Insights
Cryptocurrencies
正文
About Us
Trending
Contact Us
Advertise
UAE Edition
Rankings
Insights
Cryptocurrencies
Magazines
Industry
Geography
Insights
Cryptocurrencies
Magazines
Industry
Geography
How Demis Hassabis, the CEO of Google DeepMind, is Advancing AI Through Scientific Discovery
Demis Hassabis is pushing AI beyond chatbots through AlphaFold, AlphaGenome, Co-Scientist and drug discovery, creating new tools that help scientists study biology, test ideas and accelerate research.
Written By:
Pardeep Sharma
Reviewed By:
Achu Krishnan
Published on
29 Sep 2026, 11:06 am
Updated on
29 Sep 2026, 11:06 am
Key Takeaways -
AlphaGenome gives researchers a new way to study the effects of billions of possible DNA variants.
Co-Scientist uses Gemini-based AI agents to create, test and refine scientific hypotheses.
Hassabis now has a broader Alphabet science role while Isomorphic Labs expands its AI drug discovery work.
Demis Hassabis has moved into a new role at Alphabet, while continuing to focus on using advanced AI to address difficult scientific problems. On August 5, 2026, Hassabis became Chair of Google DeepMind and Chief Scientist of Alphabet. Koray Kavukcuoglu took responsibility for day-to-day Google DeepMind operations and Gemini development. Hassabis also remains CEO of Isomorphic Labs, where AI has a direct role in drug discovery.
AlphaFold Set the Foundation for AI Science
AlphaFold
remains the clearest example of Hassabis’s science-first approach. Google says the AlphaFold database has reached more than 3 million researchers in more than 190 countries. The database now contains more than 200 million predicted protein structures. AlphaFold-related research has produced more than 35,000 citations, while more than 200,000 papers have used AlphaFold 2.
AlphaFold 2 addressed a protein structure problem that had